Donald Trump’s pharmaceutical tariff to have ‘limited’ impact on biotech giant CSL: UBS
admin 8 hours agoUSA UpdateComments Off on Donald Trump’s pharmaceutical tariff to have ‘limited’ impact on biotech giant CSL: UBS3 Views
Investment bank UBS expects Donald Trump’s tariff threat on pharmaceuticals to have ‘limited’ impact on biotech giant CSL, especially if plasma products are excluded.
